NIH #P01CA101937
Core A - Clinical Database.
- Amount
- $300K–$400K
- Period
- 2003-09-19 → 2024-11-30
- PIs
- 1
Awarded at WASHINGTON UNIVERSITY
Peter Westervelt
Full Professor(heuristic)
Acute Myeloid Leukemia Research · Hematology
Compare more Hematology professors.
h-index90
i10-index190
Publications465
Citations63,087
Grants
5 total · 0 active
NIH #UG1HL109137
A Phase II Study of Cytokine Induced Memory-like (CIML) Natural Killer (NK) Cell Adoptive Therapy after Haploidentical Donor Hematopoietic Cell Transplantation.
- Amount
- $100K–$200K
- Period
- 2017-07-27 → 2024-06-30
- PIs
- 1
Awarded at WASHINGTON UNIVERSITY
NIH #U10HL109137
Sargrastim and Plerixafor vs. Filgrastim for Allogeneic Stem Cell Mobilization
- Amount
- $100K–$200K
- Period
- 2011-08-08 → 2017-06-30
- PIs
- 1
Awarded at WASHINGTON UNIVERSITY
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial (Blood Advances)2026-06-05
- New preprint: Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial2024-09-16
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-27
Data may not be current